The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Bronchiectasis
A recently (2010s) described pattern in transplant recipients
Publications
Dury S, Colosio C, Etienne I, Anglicheau D, Merieau E, Caillard S, Rivalan J, Thervet E, Essig M, Babinet F, Subra JF, Toubas O, Rieu P, Launois C, Perotin-Collard JM, Lebargy F, Deslée G, Spiesser group
Bronchiectasis diagnosed after renal transplantation: a retrospective multicenter study.
BMC pulmonary medicine. 2015;15:141
Hypogammaglobulinemia and bronchiectasis in mycophenolate mofetil-treated renal transplant recipients: an emerging clinical phenomenon?
Clinical transplantation. 2011;25(3):417-9
Mycophenolate mofetil and bronchiectasis in pediatric transplant patients.
Transplantation. 2006;82(10):1386
Mycophenolate mofetil and bronchiectasis in kidney transplant patients: a possible relationship.
Transplantation. 2006;81(2):287-9
Improved outcome of pediatric kidney transplantations in the Netherlands -- effect of the introduction of mycophenolate mofetil?
Pediatric transplantation. 2005;9(1):104-11
Bronchiectasis in children after renal or liver transplantation: a report of five cases.
Pediatric transplantation. 2004;8(1):71-4